Firstly, we acknowledge that Genpact has a significantly high ROE. Additionally, the company's ROE is higher compared to the industry average of 16% which is quite remarkable. This likely paved the ...

Genpact (NYSE:G – Free Report) had its price objective boosted by Robert W. Baird from $38.00 to $44.00 in a research note ...

Investors need to pay close attention to Genpact (G) stock based on the movements in the options market lately.

Genpact's new 3+1 Execution Framework and external tailwinds are driving improved performance and competitive advantages. Its Q2-2024 results exceeded revenue and EPS estimates, showcasing strong ...

GenAI is undoubtedly changing how data scientists and analysts work, including tools, processes, and deliverables. Here’s ...

NEW YORK, Oct. 10, 2024 /PRNewswire/ -- Genpact (NYSE: G) will report its financial results for the third quarter ended September 30, 2024 after the close of the U.S. financial markets on ...

Partners and clients across industries gather at exclusive eventNEW YORK, Oct. 10, 2024 /PRNewswire/ -- Genpact (NYSE: G ), a ...

Genpact (G) is a stock many investors are watching right now. G is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. The stock is trading with P/E ratio of 11.73 right now.

FinTech LIVE 2024 is just a week away! Explore the full speaker lineup and get ready to connect with top fintech leaders. Don ...

NEW YORK, Oct. 10, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, hosted its AI Day today, bringing together ...